All Stories

  1. c-Jun N-Terminal Kinases in Alzheimer’s Disease: A Possible Target for the Modulation of the Earliest Alterations

    Article • Journal of Alzheimer s Disease, June 2021, IOS Press

    Professor Carme Auladell

  2. A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease

    Article • Current Pharmaceutical Design, May 2020, Bentham Science Publishers

    Professor Carme Auladell, Dr Antonio Camins

  3. Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease

    Article • Expert Opinion on Investigational Drugs, December 2018, Taylor & Francis

    Dr Antonio Camins, Patricia Manzine, Professor Carme Auladell

  4. Experimental Models for Aging and their Potential for Novel Drug Discovery

    Article • Current Neuropharmacology, July 2017, Bentham Science Publishers

    Professor Carme Auladell, Dr Antonio Camins

  5. Early alterations in Alzheimer diseases

    Article • Experimental Gerontology, September 2015, Elsevier

    Professor Carme Auladell

  6. Dithiocarb (N,N-diethyldithiocarbamate, DEDTC) decreases levels of biogenic monoamines in the adult mouse brain

    Article • Neuropathology and Applied Neurobiology, September 2014, Wiley

    Professor Carme Auladell

  7. Glutamate-like Immunoreactivity and Fate of Cajal-Retzius Cells in the Murine Cortex as Identified with Calretinin Antibody

    Article • Cerebral Cortex, January 1995, Oxford University Press (OUP)

    Professor Carme Auladell